Serodiagnosis of Chlamydia pneumoniae infection using three inclusion membrane proteins

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 1, 2010, Pages 55-61

  Hongliang, Chen ^a   Zhou, Zhou ^a   Zhan, Hu ^a   Yanhua, Zeng ^a   Zhongyu, Li ^a   Yingbiao, Lin ^b   Guozhi, Dai ^b   Yimou, Wu ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Chenzhou No1 People's Hospital   (China)

Author keywords

Chlamydophila pneumoniae; ELISA; Recombinant antigens; Serodiagnosis

Indexed keywords

CPN 0146 PROTEIN; CPN 0147 PROTEIN; CPN 0308 PROTEIN; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIUM DETECTION; BLOOD DONOR; CHILD; CHLAMYDIAL PNEUMONIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; WESTERN BLOTTING;

ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

CHLAMYDOPHILA PNEUMONIAE;

EID: 75749139320     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20367     Document Type: Article

References (22)

1. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-168.
2. Kuo C-C, Jackson LA, Campbell LA, et al. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-461.
3. Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: Current status of diagnostic methods. Clin Infect Dis 2007;44:568-576.
4. Sessa R, Nicoletti M, Di Pietro M, et al. Chlamydia pneumoniae and atherosclerosis: Current state and future prospectives. Int J Immunopathol Pharmacol 2009;22:9-14.
5. Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: Critical assessment of diagnostic methods and relevance to treatment studies. Clin Micro 2002;15:1-20.
6. Belland RJ, Ouellette SP, Gieffers J, Byrne GI. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 2004;6:117-127.
7. Verkooyen RP, Willemse D, Hiep-van Casteren SC, et al. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J Clin Microbiol 1998;36:2301-2307.
8. Paldanius M, Bloigu A, Leinonen M, Saikku P. Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: Comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit. Clin Diagn Lab Immunol 2003;10:8-12.
9. Wong YK, Sueur JM, Fall CH, Orfila J, Ward ME. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae. J Clin Pathol 1999;52:99-102.
10. Bennedsen M, Berthelsen L, Lind I. Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies. Clin Diagn Lab Immunol 2002;9:833-839.
11. Miyashita N, Ouchi K, Kawasaki K, et al. Evaluation of enzymelinked immunosorbent assay for Chlamydophila pneumoniae-specific immunoglobulin M in acute respiratory tract infection. Respirology 2008;13:299-302.
12. Kutlin A, Tsumura N, Emre U, Roblin PM, Hammerschlag MR. Evaluation of Chlamydia immunoglobulinM(IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection. Clin Diagn Lab Immunol 1997;4:213-216.
13. Luo J, Liu G, Zhong Y, Jia T, Zhong G. Characterization of hypothetical proteins Cpn0146, 0147, 0284 & 0285 that are predicted to be in the Chlamydia pneumoniae inclusion membrane. BMC Microbiol 2007;15:7-38.
14. Luo J, Jia T, Flores R, Chen D, Zhong G. Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion membrane. Infect Immun 2007;75:497-503.
15. Harry T, Theophil S, Julian G. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 1979;76:4350-4354.
16. Masse J. Day-to-day variation in iron-status indices. Am J Clinical Nutrition 1992;55:1187-1189.
17. Kalay N, Kutukoglu I, Ozdogru I, et al. The relationship between Chlamydophila pneumoniae IgG titer and coronary atherosclerosis. Cardiol J 2008;15:245-251.
18. Numazaki K, Ikebe T, Chiba S. Detection of serum antibodies against Chlamydia pneumoniae by ELISA. FEMS Immunol Med Microbiol 1996;14:179-183.
19. Sueur JM, Beaumont K, Cabioch T, Orfila J, Betsou F. Diagnostic value of an ELISA using a recombinant 54 kDa species-specific protein from Chlamydia pneumoniae. Clin Microbiol Infect 2006;12:470-477.
20. Kazemi B, Seyed N, Bandehpour M, Sharifnia Z, Pakzad P. Cloning, expression and purification of truncated Chlamydia trachomatis outer membrane protein 2 (omp2) and its application in an ELISA assay. Iran J Immunol 2008;5:148-155.
21. Wolf K, Fischer E, Mead D, et al. Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect Immun 2001;69:3082-3091.
22. Montigiani S, Falugi F, Scarselli M, et al. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun 2002;70:368-379.